Chinese Pharma Cracking The U.S. Market Via Reverse Mergers Draw Attention From Authorities
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - A number of Chinese companies publicly traded in the U.S., including several in the pharmaceutical space, have come under the spotlight in the last 18 months after getting to market through reverse mergers